NASDAQ:VRAY - Viewray Stock Price, Forecast & News

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

Viewray Inc (NASDAQ:VRAY) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.21) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The business had revenue of $20.90 million for the quarter, compared to the consensus estimate of $20.66 million. Viewray had a negative return on equity of 75.41% and a negative net margin of 110.61%. Viewray's revenue for the quarter was up 18.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.39) earnings per share. View Viewray's Earnings History.

Viewray is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viewray.

Viewray issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17-17 million, compared to the consensus revenue estimate of $18.27 million.

9 brokers have issued twelve-month price objectives for Viewray's shares. Their forecasts range from $5.00 to $9.00. On average, they anticipate Viewray's stock price to reach $6.44 in the next twelve months. This suggests a possible upside of 106.6% from the stock's current price. View Analyst Price Targets for Viewray.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Viewray.

News stories about VRAY stock have trended very negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Viewray earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Viewray.

Some companies that are related to Viewray include Natus Medical (NTUS), AxoGen (AXGN), Cutera (CUTR), TransMedics Group (TMDX), Zynex (ZYXI), Stereotaxis (STXS), Semler Scientific (SMLR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Fonar (FONR), Soleno Therapeutics (SLNO), Edap Tms (EDAP), BioSig Technologies (BSGM), Second Sight Medical Products (EYES) and IRIDEX (IRIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), Amarin (AMRN), Amicus Therapeutics (FOLD), Iovance Biotherapeutics (IOVA), Pieris Pharmaceuticals (PIRS), Sorrento Therapeutics (SRNE), Sarepta Therapeutics (SRPT) and Viking Therapeutics (VKTX).

(VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Viewray's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Rhenman & Partners Asset Management AB (0.75%), Pennsylvania Trust Co (0.13%) and Alpine Global Management LLC (0.08%). Company insiders that own Viewray stock include Fmr Llc, International Ltd Fosun, James F Dempsey, Orbimed Advisors Llc, Scott William Drake and Shahriar Matin. View Institutional Ownership Trends for Viewray.

VRAY stock was acquired by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB, Alpine Global Management LLC and Pennsylvania Trust Co. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake and Shahriar Matin. View Insider Buying and Selling for Viewray.

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VRAY stock can currently be purchased for approximately $3.12.

Viewray has a market capitalization of $310.16 million and generates $80.96 million in revenue each year. The company earns $-76,400,000.00 in net income (profit) each year or ($0.98) on an earnings per share basis. View Additional Information About Viewray.

The official website for Viewray is http://www.viewray.com/.

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]